One new flavonol glycoside, named cleomeside C (1), together with eight known flavonol glycosides (2-9) were isolated by various chromatography methods from the leaves of Cleome chelidonii. Their structures were elucidated by IR, UV, HR-ESI-MS, NMR (1D & 2D) experiments. Compounds 2-8 were isolated for the first time from the genus Cleome. The cytotoxicity and hepatoprotective activity in HepG2 human hepatoma cell line of compounds (1-3 and 6) were measured by MTT assay. At the concentration of 25 μM and 50 μM, compound 2 as well as compound 3 at 25 μM showed cytotoxic activity (cell viability was decreased 21.7%, 31.8% and 21.8%, respectively, compared to control). Compounds 2 and 6 expressed hepatoprotective effect at the concentration of 100 µM with prevention percentage of 32.3% and 34.3%, respectively, compared to that of 80.3% of quercetin positive control).
, quercetin 3-O-[β-D-(6-pcoumaroyl)glucopyranosyl-(1→2)]-α-L-rhamnopyranoside 7-O-α-Lrhamnopyranoside (7) [15] , kaempferol 3-O--L-(2,4-Odiacetyl)rhamnopyranoside (8) [16] , kaempferol 3-O-[α-Lrhamnopyranosyl-(1→6)]-β-D-glucopyranoside (9) [17] (Figure 1 ) from the methanol extract of the dried leaves C. chelidonii collected in Ben Cat, Binh Duong province, Viet Nam. Among them, 2-8 were isolated for the first time from the genus Cleome.
Compound 1 was obtained as a yellow amorphous powder. Its molecular formula was determined to be C 58 H 64 O 29 by HR-ESI-MS at m/z 1247.3399 [M+Na] + (calcd for C 58 H 64 O 29 Na 1247.3431). The aglycone of 1 was identified as the kaempferol, according to observation of fifteen carbons in 13 C-NMR and DEPT spectrum, including one carbonyl carbon at δ C 177.4 (C-4), six oxygenated aromatic carbons at δ C 156.2 (C-2), 133.6 (C-3), 160.7 (C-5), 161.6 (C-7), 155.7 (C-9), 160.2 (C-4), two quaternary aromatic carbons δ C 105.5 (C-10), 120.1 (C-1), six non-oxygenated aromatic carbons at δ C 99.3 (C-6), 94.0 (C-8), 115.3 (C-3, C-5), 130.5 (C-2, C-6) The HMBC spectrum (Figure 2) , showed correlations between four anomeric protons at δ H 5.76 (H-1), 4.48 (H-1), 4.42 (H-1), 5.50 (H-1) and four carbons at δ C 133.6 (C-3), 78.6 (C-2), 80.2 (C-3) and 161.6 (C-7), respectively. Furthermore, two oxymethylen protons of Glc I and Glc II at δ H 4.33 (H-6), 4.28 (H-6) were correlated with two carbonyl carbons at δ C 166.5 (C-1a) and 166.4 (C-1b), respectively. Based on data of HR-ESI-MS, NMR and previous papers [9] [10] [11] , the structure of 1 was determined
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O-α-L-rhamnopyranoside, and named cleomeside C. The cytotoxicity (Table 2 ) and hepatoprotective effect ( All compounds did not effect on cell growth at concentration of 100 µM. Hence, these concentrations were studied on their hepatoprotective effect against CCl 4 -induced hepatotoxicity in HepG2 cells. Compound 2 and 6 expressed hepatoprotective effect at the concentration of 100 µM with prevention percentage of 32.3% and 34.3%, respectively compared to that of 80.3% of quercetin positive control). 
Experimental
General: IR spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer (Bremen, Germany), UV spectra on a Jasco V-630 spectrophotometer (Tokyo, Japan), the high resolution electrospray ionization mass spectrometric analysis (HR-ESI-MS) on a Bruker MicroTOF-QII spectrometer (Bruker Daltonik GmbH, Bremen, Germany). The 1 H-NMR (500 MHz), 13 C-NMR (125 MHz), DEPT, COSY, HSQC, HMBC and NOESY spectra were performed on a Bruker AM500 FT-NMR spectrometer using tetramethylsilane (TMS) as internal standard. Column chromatography was carried out using silica gel normal-phase (230-400 mesh) and reversedphase (Merck KGaA, 64271 Darmstadt, Germany). Analytical TLC was carried out in silica gel plates (Kieselgel 60 F 254 , Merck). Compounds were visualized by spraying with aqueous 10% H 2 SO 4 and heating for 3-5 min. 
Acid hydrolysis:
The procedure was the same as thatreported previously [18, 19] .
The cytotoxicity and hepatoprotective assay: The assay was performed using the MTT method, as previously described [20, 21] . For the cytotoxicity, the percentage of control (%) was calculated = OD 570 sample /OD 570 control x 100%. Hepatoprotective effect was evaluated via prevention percentage that means attenuation of hepatocyte injury induced by 2 mM CCl 4 and calculated as the following function: Prevention percentage = [(OD 570 CCl4 + sample -OD 570 CCl4 )/(OD 570 control -OD 570 CCl4 )] x 100%.
